A detailed history of Advisor Partners Ii, LLC transactions in Novartis Ag stock. As of the latest transaction made, Advisor Partners Ii, LLC holds 31,895 shares of NVS stock, worth $3.14 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
31,895
Previous 26,343 21.08%
Holding current value
$3.14 Million
Previous $2.66 Million 22.2%
% of portfolio
0.13%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

BUY
$94.73 - $105.13 $525,940 - $583,681
5,552 Added 21.08%
31,895 $3.25 Million
Q2 2023

Aug 10, 2023

BUY
$92.52 - $104.91 $57,269 - $64,939
619 Added 2.41%
26,343 $2.66 Million
Q1 2023

May 15, 2023

BUY
$80.03 - $92.81 $176,226 - $204,367
2,202 Added 9.36%
25,724 $2.37 Million
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $485,484 - $594,533
6,426 Added 37.59%
23,522 $2.13 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $1.28 Million - $1.49 Million
17,096 New
17,096 $1.3 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Advisor Partners Ii, LLC Portfolio

Follow Advisor Partners Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners Ii, LLC with notifications on news.